Bamaquimast

CAS No. 135779-82-7

Bamaquimast( F 10126 | L 0042 )

Catalog No. M20196 CAS No. 135779-82-7

Bamaquimast is an inhibitor of proton pump.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 62 In Stock
5MG 87 In Stock
10MG 143 In Stock
25MG 359 In Stock
50MG 512 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Bamaquimast
  • Note
    Research use only, not for human use.
  • Brief Description
    Bamaquimast is an inhibitor of proton pump.
  • Description
    Bamaquimast is an inhibitor of proton pump.
  • In Vitro
    Bamaquimast (F 10126; L 0042) is an anti-allergic or anti-inflammatory, not acting as anti-histaminics.
  • In Vivo
    ——
  • Synonyms
    F 10126 | L 0042
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Proton Pump
  • Recptor
    Proton pump
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    135779-82-7
  • Formula Weight
    303.36
  • Molecular Formula
    C16H21N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:29 mg/mL (95.60 mM)
  • SMILES
    CCCn1c2ccccc2nc(CCCOC(=O)NC)c1=O
  • Chemical Name
    3-Hydroxypropyl-1-propyl-2(1H)-quinoxalinone methylcarbamate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • WY-47766

    WY-47766 (OST-766) is a small molecule proton pump inhibitor that can be used to study postmenopausal osteoporosis.

  • Lansoprazole sodium

    Lansoprazole sodium is a proton pump inhibitor (PPI) and a potent inhibitor of gastric acidity which is widely used in the therapy of gastroesophageal reflux and peptic ulcer disease.

  • TAK-438 free base

    A novel potent, oral potassium-competitive acid blocker (P-CAB) that potently inhibits H+,K+-ATPase with IC50 of 19 nM.